These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 4073876)

  • 1. Effect of ketoconazole in combination with other inhibitors of sterol synthesis on fungal growth.
    Sud IJ; Feingold DS
    Antimicrob Agents Chemother; 1985 Oct; 28(4):532-4. PubMed ID: 4073876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of ketoconazole and itraconazole on growth and sterol synthesis in Pityrosporum ovale.
    Marichal P; Gorrens J; Van Cutsem J; Van Gerven F; Vanden Bossche H
    J Med Vet Mycol; 1986 Dec; 24(6):487-9. PubMed ID: 3033190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity.
    Gupta AK; Kohli Y
    Br J Dermatol; 2003 Aug; 149(2):296-305. PubMed ID: 12932235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifungal activity of the essential oil of Agastache rugosa Kuntze and its synergism with ketoconazole.
    Shin S; Kang CA
    Lett Appl Microbiol; 2003; 36(2):111-5. PubMed ID: 12535132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluconazole, itraconazole and ketoconazole in-vitro activity. A comparative study.
    Arzeni D; Barchiesi F; Ancarani F; Scalise G
    J Chemother; 1991 Jun; 3(3):139-42. PubMed ID: 1655990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitors of fungal sterol synthesis: squalene-epoxidation and C-14-demethylation.
    Berg D; Plempel M
    J Enzyme Inhib; 1989; 3(1):1-11. PubMed ID: 2487319
    [No Abstract]   [Full Text] [Related]  

  • 7. NO-donors. Part 17: Synthesis and antimicrobial activity of novel ketoconazole-NO-donor hybrid compounds.
    Konter J; Möllmann U; Lehmann J
    Bioorg Med Chem; 2008 Sep; 16(17):8294-300. PubMed ID: 18710813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sterol biosynthesis inhibitors. Secondary effects and enhanced in vivo efficacy.
    Berg D; Plempel M; Büchel KH; Holmwood G; Stroech K
    Ann N Y Acad Sci; 1988; 544():338-47. PubMed ID: 3214074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of the sterol composition of Trypanosoma (Schizotrypanum) cruzi epimastigotes by delta 24(25)-sterol methyl transferase inhibitors and their combinations with ketoconazole.
    Urbina JA; Vivas J; Visbal G; Contreras LM
    Mol Biochem Parasitol; 1995 Jul; 73(1-2):199-210. PubMed ID: 8577328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of antifungal activity of polyenzyme preparation Candidaseb using in vitro methods.
    Joshi A; Deshpande S; Dohe V; Risbud S; Bharadwaj R
    Hindustan Antibiot Bull; 2007 Feb-2008 Nov; 49-50(1-4):10-3. PubMed ID: 19957538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of antimycotic azoles on growth and sterol biosynthesis of Leishmania promastigotes.
    Beach DH; Goad LJ; Holz GG
    Mol Biochem Parasitol; 1988 Nov; 31(2):149-62. PubMed ID: 2847043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro susceptibility of filamentous fungi from mycotic keratitis to azole drugs.
    Shobana CS; Mythili A; Homa M; Galgóczy L; Priya R; Babu Singh YR; Panneerselvam K; Vágvölgyi C; Kredics L; Narendran V; Manikandan P
    J Mycol Med; 2015 Mar; 25(1):44-9. PubMed ID: 25541256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ketoconazole on sterol biosynthesis by Trypanosoma cruzi epimastigotes.
    Beach DH; Goad LJ; Holz GG
    Biochem Biophys Res Commun; 1986 May; 136(3):851-6. PubMed ID: 3521598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi in vitro.
    Odds FC
    Antimicrob Agents Chemother; 1982 Nov; 22(5):763-70. PubMed ID: 6295266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific inhibition of fungal sterol biosynthesis by SF 86-327, a new allylamine antimycotic agent.
    Ryder NS
    Antimicrob Agents Chemother; 1985 Feb; 27(2):252-6. PubMed ID: 4039119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial susceptibility patterns of fungi isolated from horses with ulcerative keratomycosis.
    Brooks DE; Andrew SE; Dillavou CL; Ellis G; Kubilis PS
    Am J Vet Res; 1998 Feb; 59(2):138-42. PubMed ID: 9492925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of propyl gallate on the activity of various antifungal drugs against filamentous fungi in vitro].
    Xu Y; Pang GR; Lü XF; Chen ZJ; Sun ST; Song JZ
    Zhonghua Yan Ke Za Zhi; 2006 Apr; 42(4):309-12. PubMed ID: 16762206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of inhibition of sterol synthesis with growth-inhibitory action of imidazole antimycotics in Candida albicans.
    Nicholas RO; Kerridge D
    J Antimicrob Chemother; 1989 Jan; 23(1):7-19. PubMed ID: 2663807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungal properties of 3-n-alkyn-1-ols and synergism with 2-n-alkyn-1-ols and ketoconazole.
    Gershon H; Jerome JA; McElwain KF
    J Pharm Sci; 1985 May; 74(5):556-8. PubMed ID: 4020633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition and interaction of cytochrome P450 of Candida krusei with azole antifungal drugs.
    Venkateswarlu K; Denning DW; Kelly SL
    J Med Vet Mycol; 1997; 35(1):19-25. PubMed ID: 9061581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.